References
- Lee S, Sugimava M, Hishikawa T, Sekigawa I, Iida N, Hashimoto H, et al.. Thrombocytopenia in systemic lupus erythematosus associated with cytomegalovirus infection. Scand J Rheumatol 1997;26:69.
- Rosner S, Ginzler EM, Diamond HS, Weiner M, Schlesinger M, Fries JF, et al.. A multicenter study of outcome in systemic lupus erythematosus: II. Causes of death. Arthritis Rheum 1982;25:612— 7.
- Nived O, Sturfelt G, Wollheim F. Systemic lupus erythemato-sus and infection: a controlled and prospective study including and epidemiologic group. Q J M 1985;55:271 —87.
- Pryor BD, Bologna SG, Kahl LE. Risk factors for serious infec-tion during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. Arthritis Rheum 1996;9:1475 — 8.
- Austin HA III, Klippel JH, Balow JE, LeRichie NG, Stein AD, Plotz PH. Therapy of lupus nephritis: controlled trial of predni-sone and cytotoxic drugs. N Engl J Med 1986;314:614 — 9.
- Hellmann DB, Petri M, Whiting-O'Keefe Q. Fatal infections in systemic lupus erythematosus: the role of opportunistic organ-isms. Medicine (Baltimore) 1987;66:341 —8.
- Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al.. The 1982 revised criteria for the classification of sys-temic lupus erythematosus. Arthritis Rheum 1982;25: 1271 —7.
- Boumpas DT, Barez S, Klippel JN, Balow JE. Intermittent cyclophosphamide for the treatment of autoimmune thrombo-cytopenia in SLE. Ann Intern Med 1990;112:674 — 7.
- Arnold JC, Heilig B, Otto G, Kommerall B, Theilinann L. Cytomegalovirus-induced severe thrombocytopenia after liver transplantation. Transplantation 1993;56:1286 — 8.
- Bowness P, Davies KA, Norsworthy PJ, Athanasiou P, Taylor-Wiedeman J, Borysiewicz LK, et al.. Hereditary Clq deficiency and systemic lupus erythematosus. Q J M 1994;87:455 —64.